Skip to Content

Pharmaceutical Sales 2006

The following is a list of the top 200 pharmaceutical drugs by retail sales in 2006, listed by U.S. sales value and brand name.
Quarterly top 100 prescription sales data now available, from Q1 2011.

Top 200 Drugs for 2006 by Sales

(By Units)

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Sales ($000) % Change 2005
1 Lipitor Pfizer Inc. 6,577,810 4.1%
2 Nexium AstraZeneca 4,060,286 18.1%
3 Prevacid Takeda Pharmaceuticals U.S.A., Inc. 3,305,778 -0.7%
4 (1) Advair Diskus GlaxoSmithKline 3,105,780 9.7%
5 (4) Singulair Merck 2,460,929 17.8%
6 (2) Effexor XR Pfizer Inc. 2,246,965 1.2%
7 Plavix Bristol-Myers Squibb Company 2,231,825 -10.0%
8 (4) Zocor Merck 2,171,312 -30.1%
9 (1) Norvasc Pfizer Inc. 2,149,017 4.3%
10 (3) Lexapro Actavis Pharma, Inc. 2,098,794 13.5%
11 (3) Seroquel AstraZeneca 2,074,734 20.7%
12 (1) Protonix Pfizer Inc. 2,020,865 3.2%
13 (1) Ambien Pfizer Inc. 1,938,649 0.3%
14 (1) Actos Takeda Pharmaceuticals U.S.A., Inc. 1,926,293 20.0%
15 (9) Zoloft Pfizer Inc. 1,772,599 -30.8%
16 (5) Wellbutrin XL Bausch Health Companies Inc. 1,670,516 26.0%
17 (2) Avandia GlaxoSmithKline 1,664,459 20.5%
18 Risperdal Janssen Pharmaceuticals, Inc. 1,656,891 12.5%
19 (3) Zyprexa Eli Lilly and Company 1,536,167 -2.6%
20 (5) Topamax Janssen Pharmaceuticals, Inc. 1,520,472 19.9%
21 (2) Toprol XL AstraZeneca 1,471,881 13.7%
22 (27) Vytorin Merck 1,469,209 105.4%
23 (6) Fosamax Merck 1,427,165 -3.8%
24 (5) Abilify Bristol-Myers Squibb Company 1,417,106 29.0%
25 (5) Levaquin Janssen Pharmaceuticals, Inc. 1,409,195 4.5%
26 (8) Lamictal GlaxoSmithKline 1,326,844 28.7%
27 (1) Celebrex Pfizer Inc. 1,326,177 6.0%
28 Lotrel Novartis Pharmaceuticals Corporation 1,292,863 16.5%
29 (2) Zyrtec Johnson & Johnson Consumer Inc. 1,163,312 10.0%
30 (11) Coreg GlaxoSmithKline 1,158,322 36.8%
31 (5) Valtrex GlaxoSmithKline 1,150,247 17.6%
32 (7) Zetia Merck 1,139,638 26.0%
33 (2) Adderall XR Takeda Pharmaceuticals U.S.A., Inc. 1,131,834 12.3%
34 (2) Aciphex Eisai Inc. 1,113,022 6.2%
35 (26) Cymbalta Eli Lilly and Company 1,084,313 90.1%
36 (9) Enbrel Amgen Inc. 1,084,243 -4.1%
37 (14) Crestor AstraZeneca 1,058,160 56.3%
38 (8) Lantus Sanofi 1,057,914 36.6%
39 (4) Diovan Novartis Pharmaceuticals Corporation 972,055 19.9%
40 (5) Tricor Abbott Laboratories 965,680 22.4%
41 (1) Concerta Janssen Pharmaceuticals, Inc. 936,240 8.1%
42 (6) Diovan HCT Novartis Pharmaceuticals Corporation 866,738 19.7%
43 (1) Imitrex Oral GlaxoSmithKline 858,252 4.6%
44 (8) Aricept Eisai Inc. 799,967 22.7%
45 (10) Nasonex Merck 788,998 26.9%
46 (1) Viagra Pfizer Inc. 786,142 1.8%
47 (12) Flomax Boehringer Ingelheim Pharmaceuticals, Inc. 785,626 34.7%
48 (4) Actonel Actavis Pharma, Inc. 780,529 -1.5%
49 (9) Omnicef Abbott Laboratories 772,826 27.2%
50 Altace King Pharmaceuticals, Inc. 717,207 2.4%
51 (27) OxyContin Purdue Pharma LP 682,904 -46.9%
52 () Lyrica Pfizer Inc. 650,944 930.3%
53 (11) Zofran GlaxoSmithKline 645,411 16.3%
54 (14) Provigil Cephalon, Inc. 644,528 29.7%
55 (16) Lidoderm Endo Pharmaceuticals Inc. 635,892 35.1%
56 (4) Cozaar Merck 618,670 6.6%
57 Lamisil Oral Novartis Pharmaceuticals Corporation 613,006 0.7%
58 (19) Lovenox Sanofi 596,680 36.0%
59 (38) Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. 593,334 75.6%
60 (5) Detrol LA Pfizer Inc. 584,532 9.3%
61 (56) Lunesta Sepracor Inc. 583,556 120.8%
62 (8) Synthroid Abbott Laboratories 579,742 -9.4%
63 (10) Strattera Eli Lilly and Company 577,944 -10.0%
64 (8) Premarin Tabs Pfizer Inc. 576,358 -6.5%
65 (43) Pravachol Bristol-Myers Squibb Company 575,985 -56.2%
66 (33) Truvada Gilead Sciences, Inc. 569,618 74.4%
67 () Ambien CR Sanofi 552,980 >999
68 (21) Actiq Abbott Laboratories 546,427 47.4%
69 (6) Depakote Abbott Laboratories 542,016 -3.8%
70 (3) Combivent Boehringer Ingelheim Pharmaceuticals, Inc. 534,477 6.6%
71 (1) Humalog Eli Lilly and Company 533,683 10.1%
72 (9) Geodon Oral Pfizer Inc. 529,350 24.8%
73 (4) Pulmicort Respules AstraZeneca 520,747 7.1%
74 (1) Trileptal Novartis Pharmaceuticals Corporation 513,429 12.0%
75 (37) Mobic Abbott Laboratories 512,978 -44.0%
76 Yasmin 28 Bayer HealthCare Pharmaceuticals Inc. 508,160 15.2%
77 (11) Evista Eli Lilly and Company 507,954 0.6%
78 (6) CellCept Genentech, Inc. 507,652 9.9%
79 (5) Humira Abbott Laboratories 505,566 28.0%
80 (1) Depakote ER Abbott Laboratories 501,961 17.2%
81 (7) Keppra UCB, Inc. 498,913 31.4%
82 (7) Skelaxin Elan Corporation plc 482,964 8.4%
83 (26) Flovent HFA GlaxoSmithKline 476,624 64.6%
84 (10) Hyzaar Merck 474,967 6.0%
85 (2) Niaspan Abbott Laboratories 473,755 24.4%
86 (8) Prograf Astellas Pharma US, Inc. 446,139 3.4%
87 (6) Arimidex AstraZeneca 446,009 28.2%
88 (3) Procrit Janssen Biotech, Inc. 418,431 6.3%
89 (11) Zelnorm Novartis Pharmaceuticals Corporation 417,116 31.1%
90 (8) Xalatan Pfizer Inc. 403,790 -1.3%
91 (5) Asacol Actavis Pharma, Inc. 388,196 14.5%
92 (20) Namenda Actavis Pharma, Inc. 386,739 36.5%
93 (13) Cialis Eli Lilly and Company 375,143 27.1%
94 (7) Reyataz Bristol-Myers Squibb Company 372,790 18.8%
95 Ortho Tri-Cyclen Lo Janssen Pharmaceuticals, Inc. 371,803 9.6%
96 (4) Avapro Bristol-Myers Squibb Company 367,239 4.7%
97 () Byetta Amylin Pharmaceuticals, Inc. 362,996 632.3%
98 (36) Duragesic Janssen Pharmaceuticals, Inc. 357,439 -37.3%
99 (13) Combivir GlaxoSmithKline 355,848 -9.4%
100 (11) Kaletra Abbott Laboratories 352,013 23.6%
101 (14) Gleevec Novartis Pharmaceuticals Corporation 338,139 24.8%
102 (20) Avelox Bayer HealthCare Pharmaceuticals Inc. 335,397 29.3%
103 (20) Allegra-D 12 Hour Sanofi 335,011 -15.8%
104 (27) Benicar HCT Daiichi Sankyo 333,894 46.8%
105 (7) Paxil CR Apotex Corp. 327,010 -1.5%
106 (15) Clarinex Merck 321,246 -9.1%
107 Xopenex Akorn, Inc. 320,084 9.2%
108 (18) Benicar Daiichi Sankyo 312,791 24.4%
109 (1) Copaxone Accredo Health Group, Inc. 305,828 7.0%
110 (7) Sustiva Bristol-Myers Squibb Company 300,944 -2.7%
111 (5) Avalide Bristol-Myers Squibb Company 300,774 12.2%
112 (10) Nasacort AQ Sanofi 299,484 -3.8%
113 (8) AndroGel Abbott Laboratories 295,593 13.3%
114 (4) Forteo Eli Lilly and Company 295,172 11.9%
115 (2) Patanol Alcon 290,912 4.8%
116 (8) Avonex Biogen 289,082 -1.2%
117 (84) Flonase GlaxoSmithKline 285,179 -72.7%
118 (16) Thalomid Bristol-Myers Squibb Company 273,921 25.7%
119 () Boniva Genentech, Inc. 270,321 387.8%
120 (16) Zofran ODT GlaxoSmithKline 267,379 24.9%
121 (76) Caduet Pfizer Inc. 266,446 91.3%
122 () Requip GlaxoSmithKline 260,813 139.5%
123 (10) Fuzeon Genentech, Inc. 256,183 15.8%
124 (20) Rhinocort Aqua AstraZeneca 254,697 -14.1%
125 (5) Norvir Abbott Laboratories 249,522 8.0%
126 (55) Tarceva Astellas Pharma US, Inc. 245,470 64.2%
127 (22) Ditropan XL Janssen Pharmaceuticals, Inc. 244,579 -17.4%
128 (4) Aldara Medicis Pharmaceutical Corporation 242,947 7.1%
129 (46) NovoLog Mix 70/30 Novo Nordisk 238,014 53.5%
130 (24) Femara Novartis Pharmaceuticals Corporation 237,495 37.0%
131 (51) Ortho Evra Janssen Pharmaceuticals, Inc. 232,914 -45.2%
132 (18) Endocet Endo Pharmaceuticals Inc. 226,805 25.3%
133 (13) RenaGel Genzyme Corporation 226,128 22.2%
134 (9) Cosopt Akorn, Inc. 223,797 17.5%
135 (21) Viread Gilead Sciences, Inc. 223,659 -17.7%
136 (11) Trizivir GlaxoSmithKline 222,562 -12.3%
137 (8) Budeprion SR Teva Pharmaceuticals USA, Inc. 211,097 -10.0%
138 (50) Restasis Actavis Pharma, Inc. 208,568 42.3%
139 (29) Zyvox Pfizer Inc. 204,629 26.1%
140 (29) Relpax Pfizer Inc. 204,508 26.2%
141 (20) Lumigan Actavis Pharma, Inc. 203,641 21.3%
142 (2) BenzaClin Sanofi 203,033 2.2%
143 (2) Humalog Mix 75/25 Pn 200,266 3.9%
144 (50) Zithromax Susp 198,939 -41.9%
145 (10) Mirapex Boehringer Ingelheim Pharmaceuticals, Inc. 197,457 15.0%
146 () Avodart GlaxoSmithKline 192,791 99.7%
147 (15) Casodex AstraZeneca 192,647 15.0%
148 (44) Astelin Meda U.S. 186,944 29.6%
149 (37) Vigamox Alcon 181,807 23.3%
150 () Epzicom GlaxoSmithKline 181,391 64.2%
151 (13) Lescol XL Novartis Pharmaceuticals Corporation 180,223 -13.6%
152 (18) Xeloda Genentech, Inc. 179,612 10.9%
153 (4) Tussionex Sanofi 179,383 -1.2%
154 (17) Coumadin Tabs Bristol-Myers Squibb Company 178,711 -14.8%
155 () Sensipar Amgen Inc. 177,838 89.1%
156 (38) Levitra Bayer HealthCare Pharmaceuticals Inc. 177,367 25.3%
157 (2) Temodar Merck 177,089 5.2%
158 (6) Inderal LA Wyeth 175,218 -1.4%
159 (12) Prilosec AstraZeneca 174,624 -5.1%
160 (7) Catapres-TTS Boehringer Ingelheim Pharmaceuticals, Inc. 174,137 6.8%
161 () NuvaRing Merck 173,168 55.0%
162 (38) Biaxin XL Abbott Laboratories 171,873 -32.6%
163 (18) Zyrtec Syrup 171,381 -8.2%
164 (16) Alphagan P Actavis Pharma, Inc. 169,571 -7.5%
165 (9) Differin Galderma Laboratories, L.P. 168,884 0.0%
166 (1) Zyrtec-D Johnson & Johnson Consumer Inc. 168,028 2.7%
167 (7) Tobradex Alcon 166,663 7.5%
168 (19) Aranesp Amgen Inc. 166,443 13.2%
169 (16) Klor-Con Sandoz Inc. 163,286 -7.1%
170 (12) Humulin N Eli Lilly and Company 163,208 -3.1%
171 DuoNeb Dey Pharma 162,376 0.7%
172 (6) Famvir GlaxoSmithKline 160,602 -1.7%
173 (45) Proscar Merck 160,135 -33.0%
174 (8) Neupogen Amgen Inc. 159,279 7.1%
175 (48) Elidel Novartis Pharmaceuticals Corporation 159,248 -36.4%
176 () Focalin XR Novartis Pharmaceuticals Corporation 159,008 320.2%
177 (35) Levoxyl King Pharmaceuticals, Inc. 158,100 -17.4%
178 Betaseron Bayer HealthCare Pharmaceuticals Inc. 157,966 3.9%
179 () Ciprodex Otic Alcon 157,513 20.1%
180 (36) Trinessa Actavis Pharma, Inc. 157,403 -15.8%
181 (2) Atacand AstraZeneca 156,519 5.4%
182 (18) Pegasys Genentech, Inc. 154,897 -5.8%
183 () Kadian Actavis Pharma, Inc. 154,653 40.5%
184 (21) Arthrotec Pfizer Inc. 152,627 -7.3%
185 () Aggrenox Boehringer Ingelheim Pharmaceuticals, Inc. 151,976 20.1%
186 (7) Humulin 70/30 Eli Lilly and Company 149,664 5.1%
187 (13) Avinza King Pharmaceuticals, Inc. 149,425 10.7%
188 (2) Pulmozyme Genentech, Inc. 145,461 -0.4%
189 () Travatan Alcon 144,801 24.4%
190 () Maxalt Merck 144,387 17.7%
191 () Dovonex Bristol-Myers Squibb Company 143,568 7.9%
192 () Risperdal Consta Janssen Pharmaceuticals, Inc. 142,446 28.2%
193 () Tri-Sprintec Teva Pharmaceuticals USA, Inc. 140,810 9.7%
194 (5) Zomig AstraZeneca 140,265 -4.0%
195 () Maxalt MLT 140,005 12.4%
196 (2) Prempro Pfizer Inc. 138,795 1.6%
197 (58) Augmentin XR Dr. Reddy's Laboratories, Inc. 138,544 -32.8%
198 () Suboxone Reckitt Benckiser Pharmaceuticals Inc. 137,067 93.5%
199 (79) Avandamet GlaxoSmithKline 136,470 -47.9%
200 () Fosamax Plus D Merck 136,034 506.5%
All Others 23,603,372 -12.7%

Source: Verispan, VONA

(By Units)

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012